Search Result

Results for "

C20

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Amylin Receptor (7) Amyloid-β (1) Apoptosis (2) Autophagy (1) Biochemical Assay Reagents (9) Calcium Channel (1) Carbonic Anhydrase (1) Ceramidase (1) CGRP Receptor (2) Cholinesterase (ChE) (1) COX (1) Cyclic GMP-AMP Synthase (1) Drug Derivative (1) Drug Intermediate (2) Drug Metabolite (1) Endogenous Metabolite (13) Epigenetic Reader Domain (1) FAAH (1) Ferroptosis (1) Fungal (1) GCGR (4) GLP Receptor (13) Hippo (MST) (1) Insulin Receptor (10) Isotope-Labeled Compounds (4) LDLR (1) Liposome (2) Microtubule/Tubulin (1) Monoamine Oxidase (1) Neurokinin Receptor (1) Parasite (1) Peptide-Drug Conjugates (PDCs) (1) Progesterone Receptor (1) Reference Standards (1) Stearoyl-CoA Desaturase (SCD) (2) STING (1) Tau Protein (1) Topoisomerase (2) TRP Channel (2) YAP (1) β-catenin (1)
By Research Areas:	Cancer (7) Endocrinology (2) Infection (5) Inflammation/Immunology (5) Metabolic Disease (38) Neurological Disease (9)
Oligonucleotides:	Phospholipids (1)

Inhibitors & Agonists

Biochemical Assay Reagents

Peptides

Natural
Products

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-P10798

Eloralintide LY-3841136	Amylin Receptor	Metabolic Disease
Eloralintide is an amylin receptor (AMYR) activator and long-acting peptide. Eloralintide selectively activates amylin receptors. Eloralintide is modified with a C20 fatty diacid moiety that binds to amylin receptors while retaining selectivity from calcitonin receptors. Eloralintide induces decreased appetite.Eloralintide reduces body weight. Eloralintide can be used for the research of obesity .

HY-P3506

Retatrutide 3 Publications Verification LY3437943	GCGR GLP Receptor	Metabolic Disease
Retatrutide (LY3437943) is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide binds human GCGR, GIPR, and GLP-1R with EC₅₀ values of 5.79, 0.0643 and 0.775 nM, respectively. Retatrutide can be used for the research of obesity .

HY-112016

C20 Ceramide (d18:1/20:0) C20 Ceramide; N-Arachidoyl-D-sphingosine	Endogenous Metabolite	Neurological Disease
C20 Ceramide (d18:1/20:0) (N-Arachidoyl-D-sphingosine) is a natural 20:0 ceramide and a N-acylsphingosine in which the ceramide N-acyl group is specified as eicosanoyl. C20 Ceramide (d18:1/20:0) acts as a key signal molecule mediating biological processes .

HY-P10798A

Eloralintide sodium LY-3841136 sodium	Amylin Receptor Calcium Channel	Metabolic Disease
Eloralintide sodium is an Amylin Receptor agonist. Eloralintide sodium selectively activates AMY1R and AMY3R in cells expressing human or rat AMY1R, AMY3R or CTR. Eloralintide sodium activates AMYRs and CTR in rats, inducing a sustained decrease in plasma Ca ²⁺ levels. Eloralintide sodium reduces appetite and body weight in both lean and obese rats. Eloralintide sodium can be used for research related to obesity .

HY-19796

Icomidocholic acid 1 Publications Verification Aramchol; C20-FABAC	Stearoyl-CoA Desaturase (SCD)	Metabolic Disease
Icomidocholic acid (Aramchol) is a lipid molecule synthesized from cholic acid and arachidic acid. Icomidocholic acid is an orally active SCD1 inhibitor and cholesterol solubilizer with antifibrotic effects. Icomidocholic acid can reduce liver fat content, dissolve cholesterol crystals and prevent gallstone formation. Icomidocholic acid can be used in the study of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) .

HY-P3506A

Retatrutide TFA 3 Publications Verification LY3437943 TFA	GLP Receptor GCGR	Metabolic Disease
Retatrutide (LY3437943) TFA is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide TFA binds human GCGR, GIPR, and GLP-1R with EC₅₀ values of 5.79, 0.0643 and 0.775 nM, respectively. Retatrutide TFA can be used for the research of obesity .

HY-P11245A

NN1213 acetate	Amylin Receptor	Metabolic Disease
NN1213 acetate, a long-acting human amylin peptide analog, is a selective Amylin receptor agonist with EC₅₀ values of 0.177 and 0.262 nM for hAMY3R and rAMY3R, respectively. NN1213 acetate significantly reduces food intake and fat mass. NN1213 acetate can reduce body weightin diet-induced obese rats. NN1213 acetate can be used for the research of obesity .

HY-P4070

Insulin icodec	Insulin Receptor	Metabolic Disease
Insulin icodec is an Insulin (HY-P0035) analog that strongly but reversibly binds to albumin. Insulin icodec has long plasma half-life. Insulin icodec modulates insulin receptor activity, controls blood glucose levels, reduces HbA_1c levels, and binds reversibly to human serum albumin. Insulin icodec can be used for the research of type 2 diabetes mellitus .

HY-158790

(R)-HTS-3	Ferroptosis	Cancer
(R)-HTS-3 is an lysophosphatidylcholine acyltransferase 3 (LPCAT3) inhibitor, with an IC₅₀ of 0.09 μM. (R)-HTS-3 suppresses the C20:4 content of PE, PC, and PS, while promoting a correspondingelevation in C22:4 phospholipids and a paradoxical increase in C20:4 phosphatidylinositol (PI) lipids .

HY-P10956

Colulintide LY3541105	Amylin Receptor CGRP Receptor	Metabolic Disease
Colulintide (LY3541105) is an amylin-calcitonin dual receptor agonist with Amylin as its scaffold. Colulintide is applicable to research related to type 2 diabetes and obesity .

HY-P10959

Macupatide LY3532226	Insulin Receptor	Metabolic Disease
Macupatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. Macupatide improves insulin secretion responses and insulin sensitivity.Macupatide can be used for the research of type 2 diabetes .

HY-N15905

C20 Glucosyl(β) ceramide (d18:1/20:0)	Biochemical Assay Reagents	Others
C20 Glucosyl(β) ceramide (d18:1/20:0) is a β-glucosyl ceramide.

HY-N15809

C20 Galactosyl(ß) ceramide (d18:1/20:0)	Biochemical Assay Reagents	Inflammation/Immunology
C20 Galactosyl(?) ceramide (d18:1/20:0) is a β-Glucosyl ceramide.

HY-P11271

Ribupatide	Insulin Receptor GLP Receptor	Metabolic Disease
Ribupatide is a dual gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist. Enicepatide can be studied in antidiabetic research .

HY-P11245

NN1213	Amylin Receptor	Metabolic Disease
NN1213, a long-acting human amylin peptide analog, is a selective Amylin receptor agonist with EC₅₀ values of 0.177 and 0.262 nM for hAMY3R and rAMY3R, respectively. NN1213 significantly reduces food intake and fat mass. NN1213 can reduce body weightin diet-induced obese rats. NN1213 can be used for the research of obesity .

HY-P11285A

LAGIPRA peptide TFA Long acting GIPRA-1 TFA	Insulin Receptor	Metabolic Disease
LAGIPRA peptide TFA is a long-acting GIP1R agonist. LAGIPRA peptide TFA enhances insulin sensitivity by augmenting glucose disposal and reduces branched-chain amino acids (BCAAs) and ketoacids. LAGIPRA peptide TFA has the potential for the research of type 2 diabetes .

HY-W414466

C20-Dihydrosphingosine D-Erythro-sphinganine C20 chain	Biochemical Assay Reagents	Metabolic Disease
C20-Dihydrosphingosine (D-Erythro-sphinganine C20 chain) is an ester product.

HY-N15352

C20 Sphingomyelin (d18:1/20:1)	Liposome	Neurological Disease
C20 Sphingomyelin (d18:1/20:1) is a sphingomyelin substance. The level of C20 Sphingomyelin (d18:1/20:1) is associated with amyotrophic lateral sclerosis and primary lateral sclerosis .

HY-149526

cGAS-IN-1	Cyclic GMP-AMP Synthase	Infection Inflammation/Immunology
cGAS-IN-1 (Compound C20) is a cyclic GMP-AMP synthase (cGAS) inhibitor with IC₅₀s of 2.28 μM (human cGAS, h-cGAS ^FL) and 1.44 μM (mouse cGAS, m-cGAS ^CD). cGAS-IN-1 can be used for the studies of autoimmune diseases and chronic inflammation .

HY-136190

TRPC6-PAM-C20	TRP Channel	Neurological Disease
TRPC6-PAM-C20 is a selective positive allosteric modulator (PAM) of TRPC6 channels. TRPC6-PAM-C20 is a potent enhancer of channel activation, enabling low basal concentrations of DAG to induce activation of the ion channel. TRPC6-PAM-C20 induces increases in intracellular Ca ²⁺ concentrations ([Ca ²⁺]i) in TRPC6-expressing HEK293 cells with an EC₅₀ of 2.37 μM. TRPC6-PAM-C20 can be used as a valuable tool to selectively exaggerate TRPC6-dependent signals .

HY-151595

Menin-MLL inhibitor-22	Epigenetic Reader Domain	Cancer
Menin-MLL inhibitor-22 (compound C20) is an orally active inhibitor of the interaction between menin and mixed lineage leukemia (MLL) (IC₅₀=7 nM). Menin-MLL inhibitor-22 binds menin protein and inhibits cancer cell growth (MV4 cells, IC₅₀=0.3 μM). Menin is a putative tumor suppressor associated with multiple endocrine neoplasia type 1 (MEN-1 syndrome) .

HY-112016A

*(E/Z)-C20* Ceramide (d18:1/20:0)** (E/Z)-C20 Ceramide; (E/Z)-N-Arachidoyl-D-sphingosine	Endogenous Metabolite	Neurological Disease
(E/Z)-C20 Ceramide (d18:1/20:0) ((E/Z)-N-Arachidoyl-D-sphingosine) is the mixture of (Z)-C20 Ceramide and (E)-C20 Ceramide .

HY-134104

C20-Sphingosine D-erythro-Sphingosine-C20	Others	Neurological Disease
C20-Sphingosine is a long-chain base (LCB) that can be used in the study of neural development .

HY-P11285

LAGIPRA peptide Long acting GIPRA-1	Insulin Receptor	Metabolic Disease
LAGIPRA peptide is a long-acting GIP1R agonist. LAGIPRA peptide enhances insulin sensitivity by augmenting glucose disposal and reduces branched-chain amino acids (BCAAs) and ketoacids. LAGIPRA peptide has the potential for the research of type 2 diabetes .

HY-N16008

C20:4 Anandamide (AEA)	Biochemical Assay Reagents	Others
C20:4 Anandamide (AEA) is a class of anandamides.

HY-P10959A

Macupatide acetate LY3532226 acetate	Insulin Receptor	Metabolic Disease
Macupatide acetate is a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. Macupatide acetate improves insulin secretion responses and insulin sensitivity.Macupatide acetate can be used for the research of type 2 diabetes .

HY-17649

EIDD-036	Progesterone Receptor	Neurological Disease
EIDD-036, is the blood-brain barrier penetrant C-20 oxime of Progesterone (HY-N0437), that binds progesterone receptor (PR) with an IC₅₀ of 171 nM. EIDD-036 is the active metabolite of EIDD-1723 (HY-125547). EIDD-036 exhibits promising challenges for rapid administration in acute trauma. EIDD-036 can be used for the study of traumatic brain injury (TBI) .

HY-W590670

C20-Dihydroceramide N-[(2S,3R)-1,3-Dihydroxyoctadecan-2-yl]icosanamide	Biochemical Assay Reagents	Others
C20-Dihydroceramide is a biochemical assay reagent.

HY-113445

Thromboxane B3	COX Endogenous Metabolite	Endocrinology
Thromboxane B3 is a prostaglandin analog derived from arachidonic acid (AA) in the cyclooxygenase (COX) metabolic pathway. Thromboxane B3 is generated from arachidonic acid (AA) in platelets and vascular endothelial cells through the catalysis of cyclooxygenase (COX) and thromboxane synthase (TXS). Thromboxane B3 has been reported to be formed by human platelets upon ingestion of eicosapentaenoic acid (C20: 5ω3) .

HY-117580

16α-Hydroxyprednisolone OH-PRED	Drug Metabolite	Inflammation/Immunology
16α-Hydroxyprednisolone (OH-PRED) is a stereoselective metabolite of the 22(R) epimer of the glucocorticoid Budesonide (HY-13580). 16α-Hydroxyprednisolone formation is catalyzed by isoenzymes within the cytochrome P450 3A (CYP3A) subfamily. 16α-Hydroxyprednisolone formation can be inhibited by antibodies targeting the CYP3A subfamily .

HY-145549

C20 Sphingomyelin (d18:1/20:0) N-eicosanoyl-D-erythro-Sphingosylphosphorylcholine; SM(d18:1/20:0)	Endogenous Metabolite	Endocrinology
C20 Sphingomyelin (d18:1/20:0) (N-eicosanoyl-D-erythro-Sphingosylphosphorylcholine; SM(d18:1/20:0)) is a naturally occurring sphingolipid. C20 Sphingomyelin (d18:1/20:0) levels are upregulated in the hippocampus of streptozotocin (HY-13753)-induced diabetic rats and in human plasma, positively correlating with insulin resistance in obese humans. C20 Sphingomyelin (d18:1/20:0) is also upregulated in the liver of a mouse model of Niemann-Pick C1 disease, a neurodegenerative cholesterol sphingolipid lysosomal storage disorder.

HY-164412

*Phosphatidylcholine (C18:2,C20:4)*	Endogenous Metabolite LDLR	Others
Phosphatidylcholine (C18:2,C20:4) is a phospholipid that can be isolated from egg yolk .

HY-P11271A

Ribupatide TFA	Insulin Receptor GLP Receptor	Metabolic Disease
Ribupatide TFA is a dual gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist. Ribupatide TFA can be studied in antidiabetic research .

HY-P3506B

Retatrutide acetate LY3437943 acetate	GCGR GLP Receptor	Metabolic Disease
Retatrutide (LY3437943) acetate is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide acetate inhibits human GCGR, GIPR, and GLP-1R with EC₅₀ values of 5.79, 0.0643 and 0.775 nM, respectively. Retatrutide acetate can be used for the research of obesity .

HY-P10591

Olatorepatide Olatorepatidum	Insulin Receptor GLP Receptor	Metabolic Disease
Olatorepatide (Olatorepatidum) is a dual gastric inhibitory polypeptide (GIP) receptor and glucagon like peptide 1 (GLP-1) receptor agonist, with antidiabetic effect .

HY-N10703

1-Oxomiltirone	Others	Others
2-Isopropyl-8,8-dimethyl-7,8-dihydrophenanthrene-3,4,5(6H)-trione is a C₂₀ -norabietane diterpenoid with anti-inflammatory activity. 2-Isopropyl-8,8-dimethyl-7,8-dihydrophenanthrene-3,4,5(6H)-trione can be isolated from sage leaves .

HY-158801

Arachidonoyl-L-carnitine chloride C20:4 Carnitine chloride; L-Arachidonoylcarnitine chloride; L-Carnitine arachidonoyl ester chloride	Endogenous Metabolite	Metabolic Disease
Arachidonoyl-L-carnitine (C20:4 Carnitine) chloride is an arachidonic acid-L-carnitine complex .

HY-W746957

GA44	Drug Intermediate	Others
GA44 is a C20-gibberellin and is an intermediate in the early 13-hydroxylation pathway .

HY-179803

C20 Ceramide (d17:1/20:0)	Others	Metabolic Disease
C20 Ceramide (d17:1/20:0) is a ceramide.

HY-114668

Camptothecin-20(S)-O-propionate Camptothecin-20-O-propionate	Topoisomerase	Cancer
Camptothecin-20(S)-O-propionate (CZ48), the C20-propionate ester of CPT, is a highly effective anticancer agent. Camptothecin-20(S)-O-propionate (CZ48) is a topoisomerase-Ι inhibitor .

HY-146935S

C20:1 Ceramide-d7	Isotope-Labeled Compounds	Others
C20:1 Ceramide-d₇ is deuterium labeled C20:1 Ceramide.

HY-P11235

Berobenatide PF-08653944; MET-097	GLP Receptor	Metabolic Disease
Berobenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist .

HY-P11270

Relsipatide BGM0504; BG128	Insulin Receptor GLP Receptor	Metabolic Disease
Relsipatide (BG128) is a dual gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist. Enicepatide can be studied in antidiabetic research .

HY-P11237

Enicepatide CT-388	GCGR Insulin Receptor	Metabolic Disease
Enicepatide is a dual gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist. Enicepatide can be studied in antidiabetic research .

HY-141635

cis-11,14-Eicosadienoic acid methyl ester	Endogenous Metabolite	Metabolic Disease
cis-11,14-Eicosadienoic acid methyl ester is a more lipid soluble form of the ω-6 C20-2 fatty acid 11(Z),14(Z)-eicosadienoic acid, a naturally occurring PUFA. 11(Z),14(Z)-Eicosadienoic acid competitively inhibits inosine 5’-monophosphate dehydrogenase (Ki=3.1 μM) and inhibits the binding of LTB4 to its receptor on neutrophils (Ki=3.0 μM). Also, serum levels of eicosadienoic acids negatively correlate with degree of sleep disturbance.3 Eicosadienoic acids are converted by desaturases, in vivo, to eicosatrienoic acids, which are potent vasodilators.

HY-139062

C6 Urea Ceramide C6 Ceramide (d18:1/6:0) Urea; Cer(d18:1/6:0) Urea; D-erythro-Urea-C6-Ceramide	Apoptosis Ceramidase Autophagy β-catenin	Cancer
C6 Urea Ceramide (Cer(d18:1/6:0) Urea) is an inhibitor of neutral ceramidase. C6 Urea Ceramide increases total ceramide levels in wild-type mouse embryonic fibroblasts (MEFs) and HT-29 colon cancer cells. C6 Urea Ceramide (5-10 μM) inhibits proliferation of HT-29 cells and induces apoptosis and autophagy, but is not toxic to non-cancerous cells. C6 Urea Ceramide decreases total and phosphorylated β-catenin levels in HT-29 and HCT116 cells, and induces colocalization of β-catenin with the 20S proteasome. C6 Urea Ceramide (1.25, 2.5, and 5 mg/kg) reduced tumor growth and increased C16, C18, C20, and C24 ceramide levels in tumor tissues in the HT-29 mouse xenograft model.

HY-CE00116

(11Z,14Z,17Z)-Icosatrienoyl-CoA C20:3(Omega-3)-CoA; Cis-(omega-3)-icosatrienoyl-CoA	Biochemical Assay Reagents	Others
(11Z,14Z,17Z)-Icosatrienoyl-CoA (C20:3(Omega-3)-CoA) is an unsaturated fatty acyl-CoA.

HY-N11436

Aconicarchamine B	Others	Others
Aconicarchamine B is a C20-diterpenoid alkaloid, which can be isolated from Aconitum carmichaelii .

HY-163635

Antifungal agent 102	Fungal	Infection
Antifungal agent 102 (compound C20) is a antifungal agent aganist B. cinerea with the EC₅₀ of 1.23 μg/mL .

HY-W127464

Arachidyl Laurate	Biochemical Assay Reagents	Others
Arachidyl Laurate is a laurate medium chain saturated (C20:0) fatty acid ester compound that can be used as a reference for the analysis of wax laurate.

Cat. No.	Product Name	Target	Research Area

HY-P10798

Eloralintide LY-3841136	Amylin Receptor	Metabolic Disease
Eloralintide is an amylin receptor (AMYR) activator and long-acting peptide. Eloralintide selectively activates amylin receptors. Eloralintide is modified with a C20 fatty diacid moiety that binds to amylin receptors while retaining selectivity from calcitonin receptors. Eloralintide induces decreased appetite.Eloralintide reduces body weight. Eloralintide can be used for the research of obesity .

HY-P3506

Retatrutide 3 Publications Verification LY3437943	GCGR GLP Receptor	Metabolic Disease
Retatrutide (LY3437943) is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide binds human GCGR, GIPR, and GLP-1R with EC₅₀ values of 5.79, 0.0643 and 0.775 nM, respectively. Retatrutide can be used for the research of obesity .

HY-P10798A

Eloralintide sodium LY-3841136 sodium	Amylin Receptor Calcium Channel	Metabolic Disease
Eloralintide sodium is an Amylin Receptor agonist. Eloralintide sodium selectively activates AMY1R and AMY3R in cells expressing human or rat AMY1R, AMY3R or CTR. Eloralintide sodium activates AMYRs and CTR in rats, inducing a sustained decrease in plasma Ca ²⁺ levels. Eloralintide sodium reduces appetite and body weight in both lean and obese rats. Eloralintide sodium can be used for research related to obesity .

HY-P3506A

Retatrutide TFA 3 Publications Verification LY3437943 TFA	GLP Receptor GCGR	Metabolic Disease
Retatrutide (LY3437943) TFA is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide TFA binds human GCGR, GIPR, and GLP-1R with EC₅₀ values of 5.79, 0.0643 and 0.775 nM, respectively. Retatrutide TFA can be used for the research of obesity .

HY-P11245A

NN1213 acetate	Amylin Receptor	Metabolic Disease
NN1213 acetate, a long-acting human amylin peptide analog, is a selective Amylin receptor agonist with EC₅₀ values of 0.177 and 0.262 nM for hAMY3R and rAMY3R, respectively. NN1213 acetate significantly reduces food intake and fat mass. NN1213 acetate can reduce body weightin diet-induced obese rats. NN1213 acetate can be used for the research of obesity .

HY-P4070

Insulin icodec	Insulin Receptor	Metabolic Disease
Insulin icodec is an Insulin (HY-P0035) analog that strongly but reversibly binds to albumin. Insulin icodec has long plasma half-life. Insulin icodec modulates insulin receptor activity, controls blood glucose levels, reduces HbA_1c levels, and binds reversibly to human serum albumin. Insulin icodec can be used for the research of type 2 diabetes mellitus .

HY-P10956

Colulintide LY3541105	Amylin Receptor CGRP Receptor	Metabolic Disease
Colulintide (LY3541105) is an amylin-calcitonin dual receptor agonist with Amylin as its scaffold. Colulintide is applicable to research related to type 2 diabetes and obesity .

HY-P10959

Macupatide LY3532226	Insulin Receptor	Metabolic Disease
Macupatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. Macupatide improves insulin secretion responses and insulin sensitivity.Macupatide can be used for the research of type 2 diabetes .

HY-P11271

Ribupatide	Insulin Receptor GLP Receptor	Metabolic Disease
Ribupatide is a dual gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist. Enicepatide can be studied in antidiabetic research .

HY-P11245

NN1213	Amylin Receptor	Metabolic Disease
NN1213, a long-acting human amylin peptide analog, is a selective Amylin receptor agonist with EC₅₀ values of 0.177 and 0.262 nM for hAMY3R and rAMY3R, respectively. NN1213 significantly reduces food intake and fat mass. NN1213 can reduce body weightin diet-induced obese rats. NN1213 can be used for the research of obesity .

HY-P11285A

LAGIPRA peptide TFA Long acting GIPRA-1 TFA	Insulin Receptor	Metabolic Disease
LAGIPRA peptide TFA is a long-acting GIP1R agonist. LAGIPRA peptide TFA enhances insulin sensitivity by augmenting glucose disposal and reduces branched-chain amino acids (BCAAs) and ketoacids. LAGIPRA peptide TFA has the potential for the research of type 2 diabetes .

HY-P11285

LAGIPRA peptide Long acting GIPRA-1	Insulin Receptor	Metabolic Disease
LAGIPRA peptide is a long-acting GIP1R agonist. LAGIPRA peptide enhances insulin sensitivity by augmenting glucose disposal and reduces branched-chain amino acids (BCAAs) and ketoacids. LAGIPRA peptide has the potential for the research of type 2 diabetes .

HY-P10959A

Macupatide acetate LY3532226 acetate	Insulin Receptor	Metabolic Disease
Macupatide acetate is a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. Macupatide acetate improves insulin secretion responses and insulin sensitivity.Macupatide acetate can be used for the research of type 2 diabetes .

HY-P11271A

Ribupatide TFA	Insulin Receptor GLP Receptor	Metabolic Disease
Ribupatide TFA is a dual gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist. Ribupatide TFA can be studied in antidiabetic research .

HY-P3506B

Retatrutide acetate LY3437943 acetate	GCGR GLP Receptor	Metabolic Disease
Retatrutide (LY3437943) acetate is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide acetate inhibits human GCGR, GIPR, and GLP-1R with EC₅₀ values of 5.79, 0.0643 and 0.775 nM, respectively. Retatrutide acetate can be used for the research of obesity .

HY-P10591

Olatorepatide Olatorepatidum	Insulin Receptor GLP Receptor	Metabolic Disease
Olatorepatide (Olatorepatidum) is a dual gastric inhibitory polypeptide (GIP) receptor and glucagon like peptide 1 (GLP-1) receptor agonist, with antidiabetic effect .

HY-P11235

Berobenatide PF-08653944; MET-097	GLP Receptor	Metabolic Disease
Berobenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist .

HY-P11270

Relsipatide BGM0504; BG128	Insulin Receptor GLP Receptor	Metabolic Disease
Relsipatide (BG128) is a dual gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist. Enicepatide can be studied in antidiabetic research .

HY-P11237

Enicepatide CT-388	GCGR Insulin Receptor	Metabolic Disease
Enicepatide is a dual gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist. Enicepatide can be studied in antidiabetic research .

HY-P11262

GUB021794	GLP Receptor	Metabolic Disease
GUB021794 is a potent and highly selective glucagon-like peptide-1 receptor (GLP-1R) agonist developed using the streaMLine platform with an EC₅₀ value of 18 pM. GUB021794 has a very weak activity against SCTR, with an EC₅₀ value of 190 nM. GUB021794 can significantly reduce the body weight, food intake, and total fat mass of mice in a diet-induced obesity (DIO) model. GUB021794 can be used for research on obesity/diabetes .

HY-P10881

Ganipatide	Peptide-Drug Conjugates (PDCs)	Metabolic Disease
Ganipatide is a 1-31-Glucose-dependent insulinotropic polypeptide. Ganipatide is promising for research of diabetes .

HY-P11664

Anvoglutide	GLP Receptor	Metabolic Disease Inflammation/Immunology
Anvoglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist with antidiabetic and obesity effects .

HY-P11670

Linvixdutide	GLP Receptor	Metabolic Disease
Linvixdutide is a glucagon and glucagon-like peptide 1 receptor (GLP-1R) agonist with anti-obesity effects .

HY-P11830

UDA-6	Amylin Receptor	Metabolic Disease
UDA-6 is a potent calcitonin and amylin receptor agonist (DACRA). UDA-6 induces weight loss, improves metabolic and hepatic parameters, and stabilizes active receptor states in obesity rats. UDA-6 can be used for the research of obesity .

HY-P11587

BGM1812	Amylin Receptor CGRP Receptor	Metabolic Disease
BGM1812 is a dual agonist of amylin (hAMY3R) (EC₅₀ = 0.627 nM) and CGRP Receptor (hCTR) (EC₅₀ = 2.27 nM). BGM1812 achieves weight loss, increases the proportion of lean body mass, and reduces fat mass in diet-induced obese (DIO) rats. BGM1812 is applicable to research related to obesity .

HY-P11235A

Berobenatide acetate PF-08653944 acetate; MET-097 acetate

HY-P11674

Zantrutide	GLP Receptor	Metabolic Disease
Zantrutide is a glucagon, gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist. Zantrutide can be used for the study of metabolic diseases .

HY-P11666

Brenipatide LY-3537031	GLP Receptor	Metabolic Disease
Brenipatide (LY-3537031) is a dual glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP) receptor agonist. Brenipatide can be used for the study of metabolic disorders, obesity and diabetes .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-112016

C20 Ceramide (d18:1/20:0) C20 Ceramide; N-Arachidoyl-D-sphingosine	Structural Classification Alkaloids Human Gut Microbiota Metabolites Classification of Application Fields Other Alkaloids Other Diseases Endogenous metabolite Disease Research Fields Source Classification	Endogenous Metabolite
C20 Ceramide (d18:1/20:0) (N-Arachidoyl-D-sphingosine) is a natural 20:0 ceramide and a N-acylsphingosine in which the ceramide N-acyl group is specified as eicosanoyl. C20 Ceramide (d18:1/20:0) acts as a key signal molecule mediating biological processes .

HY-N15905

C20 Glucosyl(β) ceramide (d18:1/20:0)	Structural Classification Lipid	Biochemical Assay Reagents
C20 Glucosyl(β) ceramide (d18:1/20:0) is a β-glucosyl ceramide.

HY-N15809

C20 Galactosyl(ß) ceramide (d18:1/20:0)	Lipid	Biochemical Assay Reagents
C20 Galactosyl(?) ceramide (d18:1/20:0) is a β-Glucosyl ceramide.

HY-N15352

C20 Sphingomyelin (d18:1/20:1)	Structural Classification Endogenous metabolite Lipid Source Classification	Liposome
C20 Sphingomyelin (d18:1/20:1) is a sphingomyelin substance. The level of C20 Sphingomyelin (d18:1/20:1) is associated with amyotrophic lateral sclerosis and primary lateral sclerosis .

HY-134104

C20-Sphingosine D-erythro-Sphingosine-C20	Natural Products Endogenous metabolite Source Classification	Others
C20-Sphingosine is a long-chain base (LCB) that can be used in the study of neural development .

HY-N16008

C20:4 Anandamide (AEA)	Lipid	Biochemical Assay Reagents
C20:4 Anandamide (AEA) is a class of anandamides.

HY-N10703

1-Oxomiltirone	Terpenoids Labiatae Samanea saman (Jacq.) Merr. Diterpenoids Plants Source Classification	Others
2-Isopropyl-8,8-dimethyl-7,8-dihydrophenanthrene-3,4,5(6H)-trione is a C₂₀ -norabietane diterpenoid with anti-inflammatory activity. 2-Isopropyl-8,8-dimethyl-7,8-dihydrophenanthrene-3,4,5(6H)-trione can be isolated from sage leaves .

HY-W746957

GA44	Structural Classification Juglandaceae Ketones, Aldehydes, Acids Juglans regia Linn. Plants Source Classification	Drug Intermediate
GA44 is a C20-gibberellin and is an intermediate in the early 13-hydroxylation pathway .

HY-N11436

Aconicarchamine B	Terpenoids Ranunculaceae Diterpenoids Aconitum carmichaeli Debx. Plants Source Classification	Others
Aconicarchamine B is a C20-diterpenoid alkaloid, which can be isolated from Aconitum carmichaelii .

HY-Z8245

20b-Dihydroprogesterone Progesterone EP impurity C	Structural Classification Microorganisms Ketones, Aldehydes, Acids Source Classification	Drug Derivative
20b-Dihydroprogesterone (Compond III) is a C-21 steroid found in water beetles Cybister limbatus, C. tripunctatus and C. confuses .

HY-116620

Benzomalvin C	Human Gut Microbiota Metabolites Microorganisms Endogenous metabolite Source Classification	Neurokinin Receptor
Benzomalvin C is a weak antagonist of the neurokinin-1 (NK1) receptor inhibiting binding of substance P by 46% when used at 100 μg/mL in vitro. It is also a weak inhibitor of indolamine 2,3-dioxygenase (IDO) with an IC₅₀ value of 130 μM for recombinant IDO. It is isolated from Penicillium and contains an epoxide group at C-19 and C-20, which is not present in benzomalvins A, B, or E.

HY-N10619

Gibberellin A12	Structural Classification Sechium edule (Jacq.) Sw. Ketones, Aldehydes, Acids Cucurbitaceae Plants Source Classification	Drug Intermediate
Gibberellin A₁₂ is a free C₂₀-gibberellin, serving as a gibberellin biosynthesis intermediate and metabolite precursor. Gibberellin A₁₂ exists in maturing Sechium edule seed testa, developing Pisum sativum seeds and Gibberella fujikuroi .

HY-N17885

16a,17-Dihydroxy lepenine	Structural Classification Alkaloids Other Alkaloids Ranunculaceae Aconitum carmichaeli Debx. Plants Source Classification	Others
16a,17-Dihydroxy lepenine (compound 1) is a C₂₀ diterpenoid alkaloid with an atisine-denudatine skeleton. 16a,17-Dihydroxy lepenine can be isolated from the lateral roots of Aconitum carmichaelii .

HY-N18059

Spiradine A 6-Hydroxyhetisan-11-one	Structural Classification Alkaloids Thalictrum javanicum Blume Pyrrole Alkaloids Ranunculaceae Plants Source Classification	Others
Spiradine A (6-Hydroxyhetisan-11-one) is a C₂₀ diterpenoid alkaloid present in the roots of Thalictrum sessile (Ranunculaceae), and is originally isolated from Spiraea japonica (Rosaceae). Spiradine A may possess anti-inflammatory and analgesic activities .

Species:	Human (16) Mouse (1) Cynomolgus (3)
Tag:	His (15) Avi (1) Myc (1) GST (1) Fc (4)
Source:	HEK293 (14) Sf9 insect cells (2) E. coli (4)

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P703017

	TPX2 Protein, Human (sf9, His) C20orf1; C20orf2; DIL2; HCA519	Human	Sf9 insect cells
	TPX2 Protein, Human (sf9, His) is the recombinant human-derived TPX2, expressed by Sf9 insect cells , with His labeled tag. ,

HY-P76897

	EDEM2 Protein, Human (HEK293, His) ER degradation-enhancing alpha-mannosidase-like protein 2; C20orf31; C20orf49	Human	HEK293
	EDEM2 Protein is involved in the endoplasmic reticulum-associated degradation (ERAD) pathway. EDEM2 Protein, Human (HEK293, His) is the recombinant human-derived EDEM2 protein, expressed by HEK293 , with C-His labeled tag.

HY-P704538

	SRXN1 Protein, Human (His, Myc) SRXN1; Sulfiredoxin-1; C20orf139; SRX; SRX1	Human	E. coli
	SRXN1 Protein, Human (His, Myc) is the recombinant human-derived SRXN1 protein, expressed by E. coli, with N-10*His & C-Myc tag.

HY-P79426

	ISM1 Protein, Human (HEK293, His) Isthmin-1; ISM1; C20orf82; ISM; Isthmin 1	Human	HEK293
	ISM1 Protein, an angiogenesis inhibitor, regulates blood vessel formation by interacting with integrin ITGAV/ITGB5. Its participation in modulating integrin-mediated cellular processes emphasizes ISM1's potential significance in finely tuned regulatory networks governing vascular development and homeostasis. ISM1 Protein, Human (HEK293, His) is the recombinant human-derived ISM1 protein, expressed by HEK293 , with N-His labeled tag.

HY-P74491

	TRIB3 Protein, Human (sf9, GST) 1 Publications Verification Tribbles homolog 3; TRB-3; SINK; C20orf97; NIPK; SKIP3	Human	Sf9 insect cells
	TRIB3 protein is an inactive kinase that centrally regulates the integrated stress response (ISR) and inhibits DDIT3/CHOP transcriptional activity. It causes DDIT3/CHOP-dependent cell death during endoplasmic reticulum (ER) stress, particularly in programmed neuronal cell death. TRIB3 Protein, Human (sf9, GST) is the recombinant human-derived TRIB3 protein, expressed by Sf9 insect cells , with N-GST labeled tag.

HY-P76537

	PDRG1 Protein, Human (His) p53 and DNA damage-regulated protein 1; PDRG1; C20orf126; PDRG	Human	E. coli
	As a component of the PAQosome complex, the PDRG1 protein may play a role in chaperone-mediated protein folding. PAQosome is composed of multiple protein complexes, including PDRG1, and coordinates the biogenesis of multiple protein complexes. PDRG1 Protein, Human (His) is the recombinant human-derived PDRG1 protein, expressed by E. coli , with N-His labeled tag.

HY-P76750

	BPIFA2 Protein, Human (HEK293, His) BPI fold-containing family A member 2; PSP; C20orf70; SPLUNC2	Human	HEK293
	The BPIFA2 protein, also known as bactericidal/permeability-increasing fold family A member 2, has significant antibacterial activity, particularly against Pseudomonas aeruginosa. The protein is effective against bacterial infections caused by Pseudomonas aeruginosa, a pathogen known to be resistant to many antibiotics. BPIFA2 Protein, Human (HEK293, His) is the recombinant human-derived BPIFA2 protein, expressed by HEK293 , with C-6*His labeled tag.

HY-P76749

	BPIFA2 Protein, Human (HEK293, Fc) BPI fold-containing family A member 2; PSP; C20orf70; SPLUNC2	Human	HEK293
	The BPIFA2 protein, also known as bactericidal/permeability-increasing fold family A member 2, has significant antibacterial activity, particularly against Pseudomonas aeruginosa. The protein is effective against bacterial infections caused by Pseudomonas aeruginosa, a pathogen known to be resistant to many antibiotics. BPIFA2 Protein, Human (HEK293, Fc) is the recombinant human-derived BPIFA2 protein, expressed by HEK293 , with C-hFc labeled tag.

HY-P77733

	LAMP5 Protein, Mouse (HEK293, Fc) BAD-LAMP; LAMP-5; BADLAMP; C20orf103; dJ1119D9.3; UNC-43	Mouse	HEK293
	LAMP5 Protein significantly contributes to short-term synaptic plasticity in a specific subset of GABAergic neurons in the brain. LAMP5 Protein, Mouse (HEK293, Fc) is the recombinant mouse-derived LAMP5 protein, expressed by HEK293 , with C-hFc labeled tag.

HY-P700774

	LAMP5 Protein, Cynomolgus (HEK293, His) BAD-LAMP; LAMP-5; BADLAMP; C20orf103; dJ1119D9.3; UNC-43	Cynomolgus	HEK293
	LAMP5 belongs to the LAMP (lysosome-associated membrane protein) family, which consists of multiple members. LAMP5 Protein, Cynomolgus (HEK293, His) is the recombinant cynomolgus-derived LAMP5 protein, expressed by HEK293 , with C-His labeled tag.

HY-P701252

	RPRD1B Protein, Human (HEK293, N-His) Regulation of nuclear pre-mRNA domain-containing protein 1B; C20orf77; CREPT	Human	HEK293
	RPRD1B, is a necessary scaffolding protein that maintains genetic integrity by regulating resolution of R-loops at both the transcription termination and DNA double-strand break (DSB) repair levels. In endometrial cancers, RPRD1B accelerates cell cycle through up-regulating Cyclin D1, CDK4, and CDK6. In addition, RPRD1B enhancse transcription of CCND1 and promotes cell proliferation by interacting with RNA polymerase II. RPRD1B enhances the β-Catenin·TCF4 transcriptional activity in response to Wnt signaling. RPRD1B Protein, Human (HEK293, N-His) is the recombinant human-derived RPRD1B protein, expressed by HEK293 , with N-6*His labeled tag.

HY-P76178

	BPIFB1 Protein, Human (HEK293, His) BPI fold-containing family B member 1; VEMSGP; BPIFB1; C20orf114; LPLUNC1	Human	HEK293
	The BPIFB1 protein may play a crucial role in innate immunity, particularly in the mouth, nose, and lungs, against microbial threats. It binds to bacterial lipopolysaccharide (LPS), modulates cellular responses and affects LPS-triggered immune signaling pathways. BPIFB1 Protein, Human (HEK293, His) is the recombinant human-derived BPIFB1 protein, expressed by HEK293 , with C-His labeled tag.

HY-P77978

	LAMP5/BAD-LAMP Protein, Human (HEK293, Fc) BAD-LAMP; LAMP-5; BADLAMP; C20orf103; dJ1119D9.3; UNC-43	Human	HEK293
	LAMP5/BAD-LAMP protein plays a role in short-term synaptic plasticity within a specific subset of GABAergic neurons in the brain. LAMP5/BAD-LAMP Protein, Human (HEK293, Fc) is the recombinant human-derived LAMP5/BAD-LAMP protein, expressed by HEK293 , with C-hFc labeled tag.

HY-P700775

	LAMP5/BAD-LAMP Protein, Human (HEK293, His) BAD-LAMP; LAMP-5; BADLAMP; C20orf103; dJ1119D9.3; UNC-43	Human	HEK293
	LAMP5/BAD-LAMP protein plays a role in short-term synaptic plasticity within a specific subset of GABAergic neurons in the brain. LAMP5/BAD-LAMP Protein, Human (HEK293, His) is the recombinant human-derived LAMP5/BAD-LAMP protein, expressed by HEK293 , with C-His labeled tag.

HY-P71436

	ZBP1 Protein, Human (His) 1 Publications Verification Z-DNA-Binding Protein 1; Tumor Stroma and Activated Macrophage Protein DLM; ZBP1; C20orf183; DLM1	Human	E. coli
	ZBP1 is an important innate sensor that defends against viruses by recognizing Z-RNA structures and inducing PANoptosis. It binds Z-RNA through TNF-α family members and stimulates RIPK3 and MLKL to activate necroptosis. ZBP1 Protein, Human (His) is the recombinant human-derived ZBP1 protein, expressed by E. coli , with C-6*His labeled tag.

HY-P77350

	DEFB127 Protein, Human (HEK293, Fc) Beta-defensin 127; Beta-defensin 27; DEFB-27; C20orf73	Human	HEK293
	The DEFB127 protein exhibits significant antibacterial activity, emphasizing its role in the innate immune system's defense against microbial threats. The ability of this protein to defend against bacterial pathogens emphasizes its importance as an effector molecule in host defense mechanisms. DEFB127 Protein, Human (HEK293, Fc) is the recombinant human-derived DEFB127 protein, expressed by HEK293 , with C-hFc labeled tag.

HY-P701230

	NFKBIE/IKB epsilon Protein, Human (His) C20orf18; HOIL-1; HOIL1; PBMEI; PGBM1; RBCK2; RNF54; UBCE7IP3; XAP3; XAP4; ZRANB4	Human	E. coli
	NFKBIE/IKB epsilon Protein crucially inhibits NF-kappa-B by forming a cytoplasmic complex, preventing its DNA-binding activity. It targets specific complexes involving p50-p65, p50-c-Rel, and interacts with subunits RELA, REL, NFKB1 (p50), and NFKB2 (p52). NFKBIE/IKB epsilon plays a pivotal role in regulating NF-kappa-B signaling, controlling nuclear translocation and transcriptional activities. NFKBIE/IKB epsilon Protein, Human (His) is the recombinant human-derived NFKBIE/IKB epsilon protein, expressed by E. coli , with N-10*His labeled tag.

HY-P77966

	IL-33 Protein, Cynomolgus (HEK293, His) C9orf26 Z; DVS27; IL1F11; NF-HEV; NFEHEV; IL33; DV27; C9ORF26; RP11-575C20.2	Cynomolgus	HEK293
	The IL-33 protein is part of the IL-1 family, a different cytokine that is critical in immune responses and inflammation. IL-33 acts through its receptor ST2 to promote the activation and recruitment of immune cells such as Th2 cells, mast cells, and eosinophils to sites of inflammation. IL-33 Protein, Cynomolgus (HEK293, His) is the recombinant cynomolgus-derived IL-33 protein, expressed by HEK293 , with N-His labeled tag.

HY-P705196

	IL-33 Protein, Cynomolgus (Biotinylated, HEK293, His-Avi) C9orf26 Z; DVS27; IL1F11; NF-HEV; NFEHEV; IL33; DV27; C9ORF26; RP11-575C20.2	Cynomolgus	HEK293

HY-P70087

	DTD1 Protein, Human (HEK293, His) rHuD-aminoacyl-tRNA deacylase 1/DTD1, His; D-tyrosyl-tRNA(Tyr) deacylase 1; DNA-unwinding element-binding protein B; DUE-B; Histidyl-tRNA synthase-related; DTD1; C20orf88; DUEB; HARS2	Human	HEK293
	The DTD1 protein, as a potential ATPase, may participate in DNA replication by helping to load CDC45 onto the prereplication complex. In addition, it can also act as an aminoacyl-tRNA editing enzyme, specifically deacylating erroneous D-aminoacyl-tRNA and erroneous glycyl-tRNA (Ala). DTD1 Protein, Human (HEK293, His) is the recombinant human-derived DTD1 protein, expressed by HEK293 , with C-6*His labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name	Chemical Structure

HY-146935S

C20:1 Ceramide-d7
C20:1 Ceramide-d₇ is deuterium labeled C20:1 Ceramide.

HY-110382S

Cyclic-di-GMP-13C20,15N10 disodium

¹³C20, ¹⁵N10-Cyclic di-GMP ( ¹³C20, ¹⁵N10-c-di-GMP) is ¹³C and ¹⁵N labeled Cyclic-di-GMP (disodium). Cyclic-di-GMP disodium is a STING agonist and a bacterial second messenger that coordinates different aspects of bacterial growth and behavior, including motility, virulence, biofilm formation, and cell cycle progression. Cyclic-di-GMP disodium has anti-cancer cell proliferation activity and also induces elevated CD4 receptor expression and cell cycle arrest. Cyclic-di-GMP disodium can be used in cancer research .

HY-N6786S

Ochratoxin B-13C20
Ochratoxin B- ¹³C₂₀ is ¹³C-labeled Ochratoxin B (HY-N6786). Ochratoxin B is an orally active secondary metabolite of Aspergillus ochraceus and non-chlorinated analog of the mycotoxin Ochratoxin A. Ochratoxin B reduces the toxic effects of Ochratoxin A (HY-N6788). Ochratoxin B inhibits cell division. Ochratoxin B causes craniofacial malformations in Xenopus laevis embryos .

HY-N6771S

Cyclopiazonic acid-13C20

Cyclopiazonic acid- ¹³C₂₀ is the ¹³C-labeled Cyclopiazonic acid (HY-N6771). Cyclopiazonic acid is an endoplasmic reticulum calcium ATPase (ECAs) inhibitor and human respiratory syncytial virus (RSV) inhibitor (EC₅₀ value of 4.13 μ M), which can reduce the antagonistic effect of 5-HT receptors in rat thoracic aorta, induce p53 dependent cell apoptosis and reproductive toxicity in mouse testes, and inhibit the biological activation of aflatoxin B .

Host:	Mouse (29) Rabbit (14)
Reactivity:	Human (43) Mouse (24) Rat (23) Monkey (5) Dog (5) Hamster (2)
Application:	IHC-P (30) ICC/IF (28) IF-Tissue (2) IP (5) IHC-F (1) WB (25) FC (17) ELISA (4)
Isotype:	IgG (14) IgG1 (15) IgG2a (6) IgG2b (8)
Conjugation:	Non-conjugated (43) Biotin (1)
Clonality:	Monoclonal (25) Recombinant (8)
Modification:	Unmodified (25)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P88521

	C20orf3 Antibody (YA8205) BSCv; C20orf3	IHC-P, FC	Human, Dog, Rat, Monkey, Mouse
	C20orf3 Antibody (YA8205) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to C20orf3.

HY-P88521A

	C20orf3 Antibody (YA8205)(PBS only) BSCv; C20orf3	IHC-P, FC	Human, Dog, Rat, Monkey, Mouse
	C20orf3 Antibody (YA8205) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to C20orf3.

HY-P88766

	C20orf43 Antibody (YA8450) C20orf43; CDAO5; HSPC164; SHUJUN-3	WB, IHC-P, ICC/IF, FC	Human
	C20orf43 Antibody (YA8450) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to C20orf43.

HY-P88851

	C20orf30 Antibody (YA8535) C20orf30; dJ1116H23.2.1; HSPC274	ICC/IF, FC	Human, Mouse, Rat
	C20orf30 Antibody (YA8535) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to C20orf30.

HY-P88766A

	C20orf43 Antibody (YA8450)(PBS only) C20orf43; CDAO5; HSPC164; SHUJUN-3	WB, IHC-P, ICC/IF, FC	Human
	C20orf43 Antibody (YA8450) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to C20orf43.

HY-P83540

	TPX2 Antibody (YA3285) DIL2; p100; DIL-2; HCTP4; FLS353; HCA519; REPP86; C20orf1; C20orf2; GD:C20orf1	WB, ICC/IF	Human
	TPX2 Antibody (YA3285) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to TPX2.

HY-P83540A

	TPX2 Antibody (YA3285)(PBS only) DIL2; p100; DIL-2; HCTP4; FLS353; HCA519; REPP86; C20orf1; C20orf2; GD:C20orf1	WB, ICC/IF	Human
	TPX2 Antibody (YA3285) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to TPX2.

HY-P88851A

	C20orf30 Antibody (YA8535)(PBS only) C20orf30; dJ1116H23.2.1; HSPC274	ICC/IF, FC	Human, Mouse, Rat
	C20orf30 Antibody (YA8535) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to C20orf30.

HY-P88868

	PDRG1 Antibody (YA8552) C20orf126; PDRG	IHC-P, FC	Human, Mouse, Rat
	PDRG1 Antibody (YA8552) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to PDRG1.

HY-P81684

	YTHDF1 Antibody (YA1429) C20orf21; DF1	WB, IP	Human, Hamster
	YTHDF1 Antibody (YA1429) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to YTHDF1.

HY-P88868A

	PDRG1 Antibody (YA8552)(PBS only) C20orf126; PDRG	IHC-P, FC	Human, Mouse, Rat
	PDRG1 Antibody (YA8552) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to PDRG1.

HY-P81684A

	YTHDF1 Antibody (YA1429)(PBS only) C20orf21; DF1	WB, IP	Human, Hamster
	YTHDF1 Antibody (YA1429) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to YTHDF1.

HY-P88510

	SLA2 Antibody (YA8194) C20orf156; MARS; SLAP-2; SLAP2	IHC-P, ICC/IF, FC	Human
	SLA2 Antibody (YA8194) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to SLA2.

HY-P88553

	PANK2 Antibody (YA8237) C20orf48; HARP; HSS; NBIA1; PKAN	WB, IHC-P, ICC/IF, FC	Human, Dog, Rat, Monkey, Mouse
	PANK2 Antibody (YA8237) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to PANK2.

HY-P88845

	NANP Antibody (YA8529) C20orf147; dJ694B14.3; HDHD4	ICC/IF, FC	Human, Mouse, Rat
	NANP Antibody (YA8529) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to NANP.

HY-P88670

	ROMO1 Antibody (YA8354) bA353C18.2; C20orf52; MTGM; MTGMP	WB, IHC-P, ICC/IF	Human, Mouse, Rat, Monkey, Dog
	ROMO1 Antibody (YA8354) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to ROMO1.

HY-P88500

	DNTTIP1 Antibody (YA8184) C20orf167; dJ447F3.4; Tdif1	IHC-P, ICC/IF	Human, Mouse, Rat
	DNTTIP1 Antibody (YA8184) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to DNTTIP1.

HY-P88945

	DTD1 Antibody (YA8629) C20orf88; DUE-B; DUEB; HARS2; pqn-68	ICC/IF	Human, Mouse, Rat
	DTD1 Antibody (YA8629) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to DTD1.

HY-P88510A

	SLA2 Antibody (YA8194)(PBS only) C20orf156; MARS; SLAP-2; SLAP2	IHC-P, ICC/IF, FC	Human
	SLA2 Antibody (YA8194) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to SLA2.

HY-P88553A

	PANK2 Antibody (YA8237)(PBS only) C20orf48; HARP; HSS; NBIA1; PKAN	WB, IHC-P, ICC/IF, FC	Human, Dog, Rat, Monkey, Mouse
	PANK2 Antibody (YA8237) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to PANK2.

HY-P88845A

	NANP Antibody (YA8529)(PBS only) C20orf147; dJ694B14.3; HDHD4	ICC/IF, FC	Human, Mouse, Rat
	NANP Antibody (YA8529) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to NANP.

HY-P88500A

	DNTTIP1 Antibody (YA8184)(PBS only) C20orf167; dJ447F3.4; Tdif1	IHC-P, ICC/IF	Human, Mouse, Rat
	DNTTIP1 Antibody (YA8184) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to DNTTIP1.

HY-P88670A

	ROMO1 Antibody (YA8354)(PBS only) bA353C18.2; C20orf52; MTGM; MTGMP	WB, IHC-P, ICC/IF	Human
	ROMO1 Antibody (YA8354) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to ROMO1.

HY-P88945A

	DTD1 Antibody (YA8629)(PBS only) C20orf88; DUE-B; DUEB; HARS2; pqn-68	ICC/IF	Human, Mouse, Rat
	DTD1 Antibody (YA8629) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to DTD1.

HY-P83559

	NDUFAF5 Antibody (YA3304) C20orf7; dJ842G6.1; bA526K24.2	WB, IHC-P, IP	Human, Mouse
	NDUFAF5 Antibody (YA3304) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to NDUFAF5.

HY-P84695

	CTNNBL1 Antibody (YA4392) NAP; P14L; PP8304; C20orf33; dJ633O20.1	WB, IHC-P, ICC/IF, FC, ELISA	Human
	CTNNBL1 Antibody (YA4392) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to CTNNBL1.

HY-P83359

	ITPA Antibody (YA3104) My049; ITPase; NTPase; C20orf37; dJ794I6.3; HLC14-06-P	WB, IHC-P	Human
	ITPA Antibody (YA3104) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to ITPA.

HY-P83559A

	NDUFAF5 Antibody (YA3304)(PBS only) C20orf7; dJ842G6.1; bA526K24.2	WB, IHC-P, IP	Human, Mouse
	NDUFAF5 Antibody (YA3304) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to NDUFAF5.

HY-P88673

	TP53RK Antibody (YA8357) BUD32; C20orf64; dJ101A2; Nori-2; Nori-2p; PRPK	IHC-P	Human, Mouse, Rat
	TP53RK Antibody (YA8357) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to TP53RK.

HY-P84695A

	CTNNBL1 Antibody (YA4392)(PBS only) NAP; P14L; PP8304; C20orf33; dJ633O20.1	WB, IHC-P, ICC/IF, FC, ELISA	Human
	CTNNBL1 Antibody (YA4392) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to CTNNBL1.

HY-P83359A

	ITPA Antibody (YA3104)(PBS only) My049; ITPase; NTPase; C20orf37; dJ794I6.3; HLC14-06-P	WB, IHC-P	Human
	ITPA Antibody (YA3104) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to ITPA.

HY-P88673A

	TP53RK Antibody (YA8357)(PBS only) BUD32; C20orf64; dJ101A2; Nori-2; Nori-2p; PRPK	IHC-P	Human, Mouse, Rat
	TP53RK Antibody (YA8357) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to TP53RK.

HY-P88450

	GNAS Antibody (YA8134) AHO; C20orf45; GNAS1; GPSA; GSA; GSP; NESP; PHP1A; PHP1B; PHP1C; POH; SgVI	IHC-P	Human
	GNAS Antibody (YA8134) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to GNAS.

HY-P88450A

	GNAS Antibody (YA8134)(PBS only) AHO; C20orf45; GNAS1; GPSA; GSA; GSP; NESP; PHP1A; PHP1B; PHP1C; POH; SgVI	IHC-P	Human
	GNAS Antibody (YA8134) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to GNAS.

HY-P82429

	TRIB3 Antibody (YA2174) C20orf97; NIPK; SINK; SKIP3; TRB3; Trib3; Tribbles homolog 3; Tribbles pseudokinase 3; Tribbles3	WB	Human
	TRIB3 Antibody (YA2174) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to TRIB3.

HY-P83500

	MRPS26 Antibody (YA3245) GI008; MRPS13; RPMS13; MRP-S13; MRP-S26; NY-BR-87; C20orf193; dJ534B8.3	WB, ICC/IF	Human
	MRPS26 Antibody (YA3245) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to MRPS26.

HY-P83500A

	MRPS26 Antibody (YA3245)(PBS only) GI008; MRPS13; RPMS13; MRP-S13; MRP-S26; NY-BR-87; C20orf193; dJ534B8.3	WB, ICC/IF	Human
	MRPS26 Antibody (YA3245) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to MRPS26.

HY-P86978

	Myt1/MTF1 Antibody (YA6671) C20orf36 antibody; KIAA0835 antibody; KIAA1050 antibody; MTF1 antibody; Myelin transcription factor 1 antibody; Myelin transcription factor I antibody; MYT1 antibody; MYT1_HUMAN antibody; MyTI antibody; PLPB1 antibody; C20orf36 antibody; KIAA0835 antibody; KIAA1050 antibody; MTF1 antibody; Myelin transcription factor 1 antibody; Myelin transcription factor I antibody; MYT1 antibody; MYT1_HUMAN antibody; MyTI antibody; PLPB1 antibody; Proteolipid protein-binding protein antibody;	WB, ICC/IF, IHC-P, IF-Tissue	Human, Mouse, Rat
	Myt1/MTF1 Antibody (YA6671) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Myt1/MTF1.

HY-P86545

	YTHDF1 Antibody (YA6237) C20orf21; DACA 1; DACA-1; Dermatomyositis associated with cancer putative autoantigen 1; YTH domain family 1; YTH domain family member 1; YTH domain family protein 1; YTHD1; YTHD1_HUMAN; Ythdf1;	WB, IHC-P, ICC/IF, IP, ELISA	Human, Mouse, Rat
	YTHDF1 Antibody (YA6237) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to YTHDF1.

HY-P86660

	Cytokeratin 20 Antibody (YA6352) Cytokeratin 20; CK 20; Cytokeratin20; K20; Keratin 20; Keratin type I cytoskeletal 20; Keratin20; KRT 20; KRT 21; KRT20; KRT21; MGC35423; Protein IT; K1C20_HUMAN.	WB, IHC-P, IHC-F, ICC/IF, IF-Tissue, FC	Human, Rat
	Cytokeratin 20 Antibody (YA6352) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Cytokeratin 20.

HY-P87362

	GNAS Antibody (YA7045) Adenylate cyclase stimulating G alpha protein antibody; AHO antibody; Alternative gene product encoded by XL exon antibody; C20orf45 antibody; dJ309F20.1.1 antibody; dJ806M20.3.3 antibody; Extra large alphas protein antibody; GNAS antibody; GNAS complex locus antibody; GNAS1 antibody	WB, IHC-P, ICC/IF	Human, Mouse, Rat
	GNAS Antibody (YA7045) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to GNAS.

HY-P85905

	Cytokeratin 20 Antibody (YA5597) CD20; CK 20; CK-20; CK20; CytokeRatin-20; CytokeRatin20; K1C20_HUMAN; K20; KA20; KeRatin 20; keRatin 20, type I; keRatin 21, Rat, homolog of; KeRatin; KeRatin type I cytoskeletal 20; KeRatin-20; KeRatin20; KRT 20; KRT 21; KRT20; KRT21; MGC35423; OTTHUMP00000164518; Protein IT; type I cytoskeletal 20	IHC-P, WB, ICC/IF, ELISA	Human, Mouse, Rat
	Cytokeratin 20 Antibody (YA5597) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to Cytokeratin 20.

HY-P86889

	GNAS Antibody (YA6582) Adenylate cyclase stimulating G alpha protein antibody; AHO antibody; Alternative gene product encoded by XL exon antibody; C20orf45 antibody; dJ309F20.1.1 antibody; dJ806M20.3.3 antibody; Extra large alphas protein antibody; GNAS antibody; GNAS complex locus antibody; GNAS1 antibody; Adenylate cyclase stimulating G alpha protein antibody; AHO antibody; Alternative gene product encoded by XL exon antibody; C20orf45 antibody; dJ309F20.1.1 antibody; dJ806M20.3.3 antibody; Extra large alphas protein antibody; GNAS antibody; GNAS complex locus antibody; GNAS1 antibody; GPSA antibody; Gs alpha subunit antibody; GSA antibody; GSP antibody; Guanine nucleotide binding protein (G protein) alpha stimulating activity polypeptide 1 antibody; Guanine nucleotide binding protein alpha stimulating activity polypeptide 1 antibody; Guanine nucleotide binding protein G(s) subunit alpha isoforms short antibody; Guanine nucleotide binding protein G(s) subunit alpha isoforms XLas antibody; Guanine nucleotide regulatory protein antibody; MGC33735 antibody; NESP antibody; NESP55 antibody; Neuroendocrine secretory protein antibody; PHP1A antibody; PHP1B antibody; PHP1C antibody; POH antibody; Protein ALEX antibody; Protein GNAS antibody; Protein NESP55 antibody; SCG6 antibody; Secretogranin VI antibody; XLalphas antibody; XLas antibody;	WB, ICC/IF, IHC-P	Human, Mouse, Rat
	GNAS Antibody (YA6582) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to GNAS.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name		Classification

HY-128395

C20-Dihydrosphingomyelin C20-DHSM; DHSM (d18:0/20:0)		Phospholipids
C20-Dihydrosphingomyelin (C20-DHSM; DHSM (d18:0/20:0)) is a saturated form of Sphingomyelin (HY-113498). C20-Dihydrosphingomyelin is a secondary component of most cell sphingolipids and its levels significantly decrease after intermittent fasting during Ramadan. C20-Dihydrosphingomyelin can be used for the development of liposome reagents .

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks